Showing results (121-130 of 182) with videos related to
Sort By:
Pageof 19
Drugs of Today (Barcelona, Spain : 1998)|June 11, 2004
GERD 2003: issues from the past and a consensus for the futureIrvin Modlin, Mark KiddBest Practice & Research. Clinical Gastroenterology|December 14, 2004
GERD 2004: issues from the past and a consensus for the futureIrvin Modlin, Mark KiddNeuroendocrinology|April 18, 2019
Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/NeoplasmsSomer Matar, Anna Malczewska, Kjell Oberg, et al.Plastic and Reconstructive Surgery|March 20, 2008
Lower blepharoplasty with capsulopalpebral fascia hernia repair for palpebral bags: a long-term prospective studyAlan A Parsa, Kevin D Lye, Nathan Radcliffe, et al.Journal of Clinical Gastroenterology|April 12, 2007
GERD evaluation: time for a new paradigm?Irvin M Modlin, Peter Malfertheiner, Richard H Hunt, et al.The Lancet. Oncology|September 5, 2020
Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapyLisa Bodei, Heiko Schöder, Richard P Baum, et al.Annals of Surgical Oncology|May 19, 2021
Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest)Irvin M Modlin, Mark Kidd, Kjell Oberg, et al.Current Gastroenterology Reports|September 15, 2012
Management of gastric carcinoids (neuroendocrine neoplasms)Mark Kidd, Bjorn I GustafssonSeminars in Oncology|February 9, 2013
Systemic therapeutic options for carcinoidMarianne Pavel, Mark Kidd, Irvin ModlinNature Reviews. Clinical Oncology|June 9, 2016
Towards a new classification of gastroenteropancreatic neuroendocrine neoplasmsMark Kidd, Irvin Modlin, Kjell ÖbergPageof 19